Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...
When Theravance called it quits on a phase 2 JAK inhibitor program last February, the South San Francisco and Dublin-based biopharma company put the majority of its chips on a head-to-head trial ...
The FINANCIAL — Boehringer Ingelheim will present new data from its broad respiratory portfolio, which includes recently approved Spiolto Respimat (tiotropium ...
Theravance Biopharma Inc.’s stock TBPH tumbled 21% early Friday,ter the biotech said a Phase 4 trial of its Yupelri treatment for patients with severe to very severe Chronic Obstructive Pulmonary ...
Theravance Biopharma (NASDAQ:TBPH) lost ~16% premarket Friday after announcing that Yupelri, its FDA-approved therapy for the lung disorder, chronic obstructive pulmonary disease (COPD), didn't reach ...
The study did not show a statistically significant difference between YUPELRI and Spiriva HandiHaler on the primary endpoint, change from baseline in trough forced expiratory volume in one second (FEV ...
WASHINGTON, Sept 23 (Reuters) - The blockbuster inhaled lung medication Spiriva, marketed by Pfizer Inc and Boehringer Ingelheim, raises the risk of heart attack, stroke and death from heart disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results